Sen. Bernie Sanders, I-Vt., sent a letter to Catalyst Pharmaceuticals Feb. 4, asking why the company is charging $375,000 for a drug that many patients could previously access for free, reports Reuters.
Pharmacy
Real-time benefit check (RTBC) is a relatively new technology that can help address the challenges of rising patient share of medication costs and medication non-adherence by surfacing prescription benefit details for patients and providers at the point of prescribing.
Drugmaker Merck ended the fourth quarter of 2018 with net income of $1.8 billion, compared to a net loss of $1 billion in the same period a year prior.
Walgreens purchased 63 pharmacies from Shopko Stores Operating Co. during a bankruptcy auction Jan. 28, reports the Milwaukee Business Journal.
Stewart Adams, PhD, a pioneering pharmacist who discovered ibuprofen, died Jan. 30 at age 95, according to BBC News.
Advertisement
Under a proposed rule HHS released Jan. 31, drug manufacturers would no longer be able to give rebates to pharmacy benefit managers, but they would be allowed to offer discounted prices directly to consumers.
A woman posed as a pharmacist and allegedly filled more than 700,000 prescriptions while working at three Walgreens locations in the Bay Area for more than 10 years, the Los Angeles Times reports.
Medicare Part D beneficiaries with serious health conditions and not receiving low-income subsidies can expect to pay anywhere from $2,622 to $16,551 out of pocket for specialty-tier drugs this year, according to a Kaiser Family Foundation analysis.
Tris Pharma expanded a nationwide recall of its infant ibuprofen over concentration issues, according to USA Today.
Members of the House Energy and Commerce Committee sent letters to three leading insulin manufacturers Jan. 30, inquiring about increasing insulin prices.